SCD and glioblastoma: Because most low-SCD lines expressed very little PTEN protein (due to homo/hemizygous deletion, mutation, promoter methylation, or microRNA across all GBM subtypes), we tested whether PTEN loss played any role in SCD inhibitor resistance.